| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/19/2004 | WO2003068919A3 Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation |
| 08/19/2004 | WO2003068799A3 Oligomeric molecules and uses thereof |
| 08/19/2004 | WO2003057134A8 Specific binding agents of human angiopoietin-2 |
| 08/19/2004 | WO2003053364A3 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| 08/19/2004 | WO2003031575A8 A hybrid fusion protein transcription regulator to induce interferon target gene expression |
| 08/19/2004 | WO2003001876A8 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 08/19/2004 | WO2002068601A3 Small peptides capable of modulating the function of cd66 (ceacam) family members |
| 08/19/2004 | WO2002068593A3 Chemosensory gene family encoding gustatory and olfactory receptors and uses thereof |
| 08/19/2004 | US20040163140 Biological material |
| 08/19/2004 | US20040163138 Nucleotide sequences coding chimeric siah-mediated-degradation-proteins (SMDPs) comprising ornithine carboxylase degratory domain for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 08/19/2004 | US20040163137 PG-3 and biallelic markers thereof |
| 08/19/2004 | US20040163136 SEL-12 related methods |
| 08/19/2004 | US20040162421 Methods and compositions for screening of human Borna disease virus |
| 08/19/2004 | US20040162419 Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
| 08/19/2004 | US20040162287 Substituted cyclohexane-1,4-diamine compounds |
| 08/19/2004 | US20040162238 using Zven1 and Zven2 polypeptides to increase chemokine production for treating intestinal motility disorders and improving gastrointestinal funciton |
| 08/19/2004 | US20040162237 Use of lp82 to treat body weight disorders |
| 08/19/2004 | US20040162236 Providing a sample; introducing the sample to an antibody that binds immunospecifically to the polypeptide (containing amino acids from 1 to 82 ); and determining the presence or amount of antibody bound to said polypeptide, thus determining the presence or amount of polypeptide in the sample |
| 08/19/2004 | US20040162234 Glycogen synthase kinase-3 inhibitors |
| 08/19/2004 | US20040161858 TNF binding ligands and antibodies |
| 08/19/2004 | US20040161849 Materials and methods relating to the transfer of nucleic acid into quiescent cells |
| 08/19/2004 | US20040161848 Adenoviral vector and related system and methods of making and use |
| 08/19/2004 | US20040161846 Producing variant viral protein from negative sense single-stranded RNA virus for use as tool in vaccine development and prevention of viral infections; viricides |
| 08/19/2004 | US20040161843 Administering a peptide fragments from proteins that function as T-cell epitopes of human cytomegalovirus(HCMV) in human are capable of directing human cytotoxic T lymphocytes (CTL) to recognize and lyse human cells to infection with HCMV |
| 08/19/2004 | US20040161840 Bax-Responsive genes for drug target identification in yeast and fungi |
| 08/19/2004 | US20040161838 NPC1L1 (NPC3) and methods of use thereof |
| 08/19/2004 | US20040161827 Comprises nucleotide sequences coding tumor suppression phosphoprotein for use as pesticide and in treatment of cell proliferative disorders; antitumor agents; bioreactors and in vitro/in vivo drug screening |
| 08/19/2004 | US20040161825 Sperm specific proteins |
| 08/19/2004 | US20040161824 expressed on the surface of sperm; can be used in contraceptive vaccine formulations; for drug screening; genetic engineering |
| 08/19/2004 | US20040161823 for treating, diagnosing, preventing, and drug screening; genetic engineering |
| 08/19/2004 | US20040161822 Protein having antithrombotic activity and method for producing the same |
| 08/19/2004 | US20040161821 Density Enhanced Phosphatase-1 (DEP-1); for drug screening agents for altering signal transduction in cells; genetic engineering |
| 08/19/2004 | US20040161816 Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
| 08/19/2004 | US20040161815 in amidation of folded polypeptides and proteins based on the use of a chemical structure element comprising an imidazole function; solid phase synthesis |
| 08/19/2004 | US20040161806 Cells having transferred proteins, and methods of use thereof |
| 08/19/2004 | US20040161805 Cardiovascular safety assay |
| 08/19/2004 | US20040161799 KOR3like-proteins and methods of modulating KOR3L-mediated activity |
| 08/19/2004 | US20040161787 Protein fragment complementation assays for high-throughput and high-content screening |
| 08/19/2004 | US20040161786 Gene panel participative in hepatic stellate cell activation |
| 08/19/2004 | US20040161775 Comprises nucleotide fsequences which code apoptosis modulator protein for use in diagnosis and treatment of cell proliferation disorders |
| 08/19/2004 | US20040161759 Using polymorphism detection to diagnose and prognose psoriasis; gene therapy |
| 08/19/2004 | US20040161756 Preparing solid support comprising immobilize nucleotide sequences coding receptor and/or enzymatic polypeptides for use in identifying modulators of genic expression |
| 08/19/2004 | US20040161754 Human erg2 potassium channel |
| 08/19/2004 | US20040161746 Method of testing allergic disease |
| 08/19/2004 | US20040161739 HIV diagnostic methods |
| 08/19/2004 | US20040161432 Subunit vaccines and processes for the production thereof |
| 08/19/2004 | US20040161425 Chemokine receptor antagonists as therapeutic agents |
| 08/19/2004 | US20040161424 Metabolic enzyme resistance; oral delivery; transporter polypeptides, encoding nucleic acids |
| 08/19/2004 | US20040161423 Extending biological half life; attaching to such as polyethylene glycol |
| 08/19/2004 | US20040161420 Designed for bacterial live vector vaccines; does not rely on antibiotic resistance; stability |
| 08/19/2004 | US20040161416 Delivering DNA sequence imparting sustained rheumatoid arthritis relief |
| 08/19/2004 | US20040161411 Antibacterial therapy with bacteriophage genotypically modified to delay inactiovation by the host defense system |
| 08/19/2004 | US20040161410 Involving nucleotide sequence 15 or 19; efficient, well tolerated |
| 08/19/2004 | US20040161408 Uses of circadian gene mPer2 |
| 08/19/2004 | US20040159821 Plurality of uniformly sized ferri- or ferromagnetizable particles encased within an organic macromolecule |
| 08/19/2004 | CA2515603A1 Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions |
| 08/19/2004 | CA2515335A1 Growth factor complexes and modulation of cell migration and growth |
| 08/19/2004 | CA2515333A1 Control of plant growth and developmental processes |
| 08/19/2004 | CA2515123A1 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2515122A1 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2515100A1 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | CA2514986A1 Mucin-like polypeptides |
| 08/19/2004 | CA2514843A1 Protein fragment complementation assays for high-throughput and high-content screening |
| 08/19/2004 | CA2514576A1 Methods for treating, preventing and detecting helicobacter infection |
| 08/19/2004 | CA2514563A1 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | CA2514510A1 Polymer conjugates of mutated neublastin |
| 08/19/2004 | CA2514449A1 Restoring function to gonadotropin releasing hormone receptor mutants |
| 08/19/2004 | CA2514270A1 Antigen/antibody or ligand/receptor glycosylated specificity exchangers |
| 08/19/2004 | CA2513905A1 Immune regulation based on the targeting of early activation molecules |
| 08/19/2004 | CA2513259A1 Cross-protective epitopes of moraxella catarrhalis and use thereof |
| 08/19/2004 | CA2512624A1 Rat receptor tyrosine kinase, kdr |
| 08/18/2004 | EP1447451A1 MAMMALIAN CELL-INFECTING VIRUS VECTOR ENCODING EPITOPE-BOUND-BETA2m AND UTILIZATION THEREOF |
| 08/18/2004 | EP1447414A2 Agonist and antagonist peptides of carcinoembryonic antigen (CEA) |
| 08/18/2004 | EP1447413A2 Full-length human cDNA |
| 08/18/2004 | EP1447412A1 Method for the characterization of proteins, isolated proteins and uses therefore |
| 08/18/2004 | EP1447411A1 Novel protein, its dna and use thereof |
| 08/18/2004 | EP1447410A1 Control of plant growth and developmental processes |
| 08/18/2004 | EP1447408A1 Amino acid loaded trityl alcohol resins, method of production of amino acid loaded trityl alcohol resins and therapeutics produced therewith |
| 08/18/2004 | EP1447398A1 Retroviral protease inhibitors |
| 08/18/2004 | EP1447099A2 Antineoplastic polyethylene conjugates of cytostatic compounds and pharmaceuticals comprising same |
| 08/18/2004 | EP1447095A1 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant |
| 08/18/2004 | EP1446733A2 Glycosylphosphatidylinositol containing polypeptides |
| 08/18/2004 | EP1446501A2 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 08/18/2004 | EP1446500A2 A method for regulating immune function in primates using the foxp3 protein |
| 08/18/2004 | EP1446496A2 Methods for ligand dicovery |
| 08/18/2004 | EP1446490A1 Chimeric plasmid comprising a replicative retroviral genome and uses thereof |
| 08/18/2004 | EP1446486A1 Transgenic organism expressing fungal mrp-like abc transporters |
| 08/18/2004 | EP1446484A1 Nucleotide sequence coding for a modified protein of interest, expression vector and method for obtaining same |
| 08/18/2004 | EP1446478A2 Dimerized growth factor and materials and methods for producing it |
| 08/18/2004 | EP1446445A2 Pore-forming agents for orthopedic cements |
| 08/18/2004 | EP1446426A2 Peptide purification by means of metal ion affinity chromatography |
| 08/18/2004 | EP1446422A2 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same |
| 08/18/2004 | EP1446421A2 Mutated gene from corynebacterium glutamicum |
| 08/18/2004 | EP1446420A2 Virulence proteins of the genus yersinia and uses thereof |
| 08/18/2004 | EP1446419A2 Therapeutic polypeptides, nucleic acids encoding the same, and methods of use |
| 08/18/2004 | EP1446417A2 Novel epidermal growth factor protein and gene, and methods of use therefor |
| 08/18/2004 | EP1446414A1 Differentially expressed genes associated with obesity and type 2 diabetes |
| 08/18/2004 | EP1446158A2 Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4 |
| 08/18/2004 | EP1446152A1 Pharmaceutical composition comprising factor vii polypeptides and protein s inhibitors |
| 08/18/2004 | EP1446137A2 Somatostatin analog and uses thereof |